Apr 14, 2025, 11:33

Leukemia Exploration and Prevention (LEAP) Grant Program

The Leukemia Exploration and Prevention LEAP Grant Program, offered by the American Cancer Society, is designed to accelerate the discovery of cancer interception or prevention therapies specifically targeting RUNX1-FPD hematologic malignancies. This initiative supports independent investigators at any career stage and encourages research that could lead to transformative cancer prevention solutions.

Eligibility Criteria

Applicants must be independent investigators at any career stage.
Must be affiliated with a non-profit academic or research institution.
Open to both U.S. and international researchers.
Proposed research must be focused on RUNX1-FPD hematologic malignancies and aim at interception or prevention strategies.

Funding Details

Research Scholar Grant (RSG)

Amount: Up to 215,000 per year
Duration: Up to 4 years
Indirect Costs: Additional 10% allowed

Team Grant

Amount: Up to $430,000 per year
Duration: Up to 4 years
Indirect Costs: Additional 10% allowed

Deadline

Application Due: December 1, 2025

For additional details or inquiries, applicants are encouraged to contact Paul Campbell, PhD, and submit their application through the Application Portal.

American Cancer Society cancer cancer funding cancer grants Cancer interception Cancer Prevention hematologic malignancies LEAP Grant Program Leukemia Exploration and Prevention (LEAP) Grant Program Leukemia Research OncoDaily Oncology oncology research Research Grants research scholar grant RUNX1-FPD team grants

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Yüksel Ürün: Science Is Better When It’s Shared